Inactive Instrument

Company Refocus Group, Inc. Other OTC

Equities

RFCS

US75865X2027

Biotechnology & Medical Research

Business Summary

Refocus Group, Inc. is a medical device company. The Company is involved in researching and developing treatments for human vision disorders, particularly for the treatment of presbyopia. The Company’s product, VisAbility Micro Insert System, is a binocular presbyopia treatment, which works outside the visual axis. VisAbility Micro Insert System is under clinical trials in the United States and aims to help patients reduce or eliminate their need for reading glasses.

Managers

Managers TitleAgeSince
Chief Executive Officer - 13-10-27
Chief Tech/Sci/R&D Officer - 12-01-31
Chief Tech/Sci/R&D Officer - 05-12-31
Corporate Officer/Principal - 07-12-31
Corporate Officer/Principal - 02-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 76 10-12-31
Chairman - 13-12-31
Director/Board Member - 05-02-28
Chief Executive Officer - 13-10-27
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 24,669,105 24,669,105 ( 100.00 %) 0 100.00 %
Stock B 0 760,000 0 0

Company contact information

Refocus Group, Inc.

9155 Sterling Street Suite 160

75063, Irving

+

http://www.refocus-group.com
address Refocus Group, Inc.(RFCS)